Page 59

Innovative Health Care Magazine

59 InnovativeHealthMag.com Philip Muccio, president and founder of AxioBionics, says the products “represent three decades of research and clinical experience in the art and science of orthotics, prosthetics, and neuroprosthetics.”  He began his career as an orthotics designer and says, “Orthotic design, by its nature, constrains the body and restricts muscle activity and movement. This seemed counterintuitive to me, when there is so much potential inherent in the body. Electrical stimulation is a new frontier that frees the body in ways previously not possible.” Every AxioBionics product addresses the nuances of living, the difference between just existence and truly enjoying yourself. Three areas in particular demonstrate the difference AxioBionics can make in a person’s life: addressing chronic pain, assuring safe mobility, and reducing muscle atrophy. For many people, chronic pain can be a significant and debilitating condition that greatly affects them and their families. It can limit one’s ability to work, sleep. and even think clearly. Over time, the constant pain weakens the patient physically and using Wearable Therapy garments, a patient can work his/her way up to a level approximating 4,000 hours per year! Naturally, this happens gradually over a prescribed period of increased use. This stimulation fights the progression of atrophy from disuse, maintains (or increases) range of motion, and increases blood circulation. It is impossible to recreate the amount of therapy patients can receive through electrical stimulation by using a therapist. For anyone dealing with partial or complete paralysis, this is a huge change. TripleFlex is another innovative AxioBionics device, designed to address footdrop, a condition in which the muscles of the foot allow the foot to drop down while walking. Patients with footdrop are in danger of tripping and falling. Neurological conditions can also weaken the hip and knee flexors and TripleFlex can correct these issues as well. TripleFlex lifts the whole leg while walking to help the other foot clear the floor. Traditional footdrop correction involves bracing the foot and ankle, limiting movement, and limiting patients to only a type of shoe that would fit the brace. By contrast, with AxioBionics TripleFlex, patients can wear shoes of their choice or psychologically. They lose muscle strength and can have problems with atrophy. For people facing this long-term debilitation, AxioBionics has developed Wearable Therapy. Wearable Therapy is an FDA approved medical pain management device. It delivers low-level electrical impulses to the areas surrounding the pain. When weighing the pain management choices, it is a conservative, low risk, noninvasive and nonpharmacological alternative to surgery or opioids. Wearable Therapy is the integration of one or more surface electrical stimulation (TENS, NMES, FES) made into a personalized garment, bundled together in a complete package. It delivers the most extensive muscle therapy available for treatment of the effects of chronic pain and other neurological conditions. There are specific garments for different parts of the body; a sleeve can assist in problems in the arm, hand, shoulders, and fingers. There are similar garments for each muscle group in the body; legs, trunk, abdominals, etc. Wearable therapy is used for the following applications: • Pain relief • Slowing or preventing disuse atrophy • Maintaining or increasing range of motion • Reeducating muscles • Relaxation of muscle spasms • Increased local blood circulation • Prevention of venous thrombosis According to research, the typical in-clinic therapy time that is covered through insurance is only 36 hours each year. In contrast, “ Through research and technology, AxioBionics offers more freedom to people that have had few real choices in the treatment of their condition “


Innovative Health Care Magazine
To see the actual publication please follow the link above